157 related articles for article (PubMed ID: 17482095)
21. Distribution of alpha-galactosidase A in normal human kidney and renal accumulation and distribution of recombinant alpha-galactosidase A in Fabry mice.
Christensen EI; Zhou Q; Sørensen SS; Rasmussen AK; Jacobsen C; Feldt-Rasmussen U; Nielsen R
J Am Soc Nephrol; 2007 Mar; 18(3):698-706. PubMed ID: 17287429
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and molecular genetic basis of Fabry disease.
Pastores GM; Lien YH
J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S130-3. PubMed ID: 12068024
[No Abstract] [Full Text] [Related]
23. Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases.
Ferraz MJ; Marques AR; Appelman MD; Verhoek M; Strijland A; Mirzaian M; Scheij S; Ouairy CM; Lahav D; Wisse P; Overkleeft HS; Boot RG; Aerts JM
FEBS Lett; 2016 Mar; 590(6):716-25. PubMed ID: 26898341
[TBL] [Abstract][Full Text] [Related]
24. Preclinical efficacy and safety of 1-deoxygalactonojirimycin in mice for Fabry disease.
Ishii S; Chang HH; Yoshioka H; Shimada T; Mannen K; Higuchi Y; Taguchi A; Fan JQ
J Pharmacol Exp Ther; 2009 Mar; 328(3):723-31. PubMed ID: 19106170
[TBL] [Abstract][Full Text] [Related]
25. Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect.
Park JL; Whitesall SE; D'Alecy LG; Shu L; Shayman JA
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1156-63. PubMed ID: 18565198
[TBL] [Abstract][Full Text] [Related]
26. Gene symbol: GLA. Disease: Fabry disease.
Serebrinsky GP; Pascucelli V; Politei JM
Hum Genet; 2006 Apr; 119(3):361. PubMed ID: 17230649
[No Abstract] [Full Text] [Related]
27. Tetrahydrobiopterin deficiency in the pathogenesis of Fabry disease.
Shen JS; Arning E; West ML; Day TS; Chen S; Meng XL; Forni S; McNeill N; Goker-Alpan O; Wang X; Ashcraft P; Moore DF; Cheng SH; Schiffmann R; Bottiglieri T
Hum Mol Genet; 2017 Mar; 26(6):1182-1192. PubMed ID: 28158561
[TBL] [Abstract][Full Text] [Related]
28. [Fabry disease].
Jakubowska E; Ryba M; Hruby Z
Przegl Lek; 2006; 63(4):218-9. PubMed ID: 17080745
[TBL] [Abstract][Full Text] [Related]
29. Fabry-database.org: database of the clinical phenotypes, genotypes and mutant α-galactosidase A structures in Fabry disease.
Saito S; Ohno K; Sakuraba H
J Hum Genet; 2011 Jun; 56(6):467-8. PubMed ID: 21412250
[TBL] [Abstract][Full Text] [Related]
30. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
Chien YH; Hwu WL
Hum Genet; 2009 Apr; 125(3):336. PubMed ID: 19309781
[No Abstract] [Full Text] [Related]
31. Human gene mutations. Gene symbol: GLA. Disease: Fabry disease.
Lin WD; Hwu WL; Liu SC; Chen CP; Tsai FJ
Hum Genet; 2007 Sep; 122(2):212. PubMed ID: 18386366
[No Abstract] [Full Text] [Related]
32. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
Chien YH
Hum Genet; 2009 Apr; 125(3):336. PubMed ID: 19309800
[No Abstract] [Full Text] [Related]
33. Gene symbol: GLA. Disease: Fabry disease.
Serebrinsky G; Scuteri R; Pascucelli V; Fernandez S
Hum Genet; 2008 Jun; 123(5):538. PubMed ID: 20960604
[No Abstract] [Full Text] [Related]
34. Gene symbol: GLA.
Spanu C; Lekanne dit Deprez RH; Groener JE; Nita CC
Hum Genet; 2007 Apr; 121(2):295. PubMed ID: 17598215
[No Abstract] [Full Text] [Related]
35. Gene symbol: GLA. Disease: Fabry disease.
Lin WD; Hwu WL; Liu SC; Tsai FJ
Hum Genet; 2008 Feb; 123(1):107. PubMed ID: 18386338
[No Abstract] [Full Text] [Related]
36. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
Ferreira S; Valbuena C; Carvalho F; Oliveira JP
Hum Genet; 2009 Aug; 126(2):352. PubMed ID: 19694060
[No Abstract] [Full Text] [Related]
37. [Fabry disease].
Okumiya T; Sugiura T; Sakuraba H
Nihon Rinsho; 2001 Mar; 59 Suppl 3():313-6. PubMed ID: 11347083
[No Abstract] [Full Text] [Related]
38. Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease.
Miller JJ; Aoki K; Reid CA; Tiemeyer M; Dahms NM; Kassem IS
Sci Rep; 2019 Jun; 9(1):9392. PubMed ID: 31253878
[TBL] [Abstract][Full Text] [Related]
39. Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy.
Thurberg BL; Fallon JT; Mitchell R; Aretz T; Gordon RE; O'Callaghan MW
Circulation; 2009 May; 119(19):2561-7. PubMed ID: 19414635
[TBL] [Abstract][Full Text] [Related]
40. Interdisciplinary approach towards female patients with Fabry disease.
Weidemann F; Niemann M; Sommer C; Beer M; Breunig F; Wanner C
Eur J Clin Invest; 2012 Apr; 42(4):455-62. PubMed ID: 22049975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
